April 29, 2015 / 10:29 AM / 2 years ago

Valeant Pharma posts profit, says CFO to step down

April 29 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc reported a quarterly profit, compared with a year-ago loss, driven by higher demand in the United States.

The company also said Chief Financial Officer Howard Schiller would step down.

Net income attributable to shareholders was $73.7 million, or 21 cents per share, in the first quarter ended March 31, compared with a loss of $22.6 million, or 7 cents per share, a year earlier.

Revenue rose about 16 percent to $2.19 billion. (Reporting by Rosmi Shaji in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below